Hold’em for Life Cancer Fellowships
Hold’em for Life Charity Challenge continues to generously support cancer research and education at the University of Toronto’s Temerty Faculty of Medicine and our partner hospitals.
The Hold’em for Life Cancer Fellowships are open to University of Toronto residents and clinical fellows pursuing cancer research at any of the Faculty’s affiliated teaching hospitals. You can read more about the fellowships and Hold'em for Life Charity Challenge here.
For information on how to apply for a fellowship, visit the awards page.
There have been over 230 Hold’em for Life Cancer Fellowships awarded to date. Below is an overview of each Hold’em Fellow and their research
Hold’em for Life Cancer Fellows:
Aarón Enrique Sáenz Trevizo
Princess Margaret Cancer Centre
Project: Treatment Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) compared to Oral Systemic Therapy after progression on Somatostatin Analogue (SSA) in Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET’s): a single center real-world experience
Aarya Murali
Princess Margaret Cancer Centre
Project: Investigating the Impact of Cellular Differentiation and Cytokine Profiles on Outcomes of Patients with Acute Myeloid Leukaemia (AML) treated with Azacitidine plus Venetoclax (Aza-Ven)
Alec Hughes
Princess Margaret Cancer Centre
Project: Development of a Prognostic Radiomic Model to Guide Patient Selection for Daily Adaptive Radiotherapy for Head and Neck Cancer
Alicia Vargas Aliaga
Princess Margaret Cancer Centre
Project: Investigating the Relationship between Per- and Polyfluoroalkyl Substances (PFAS) and Early-Onset Gastrointestinal (GI) Cancers
Audrey Desilets
Sinai Health System
Project: SHE-CAN-NATURO Project: Adding Naturopathic Medications to the Survivorship Clinic of ER+/HER2- Breast Cancer Patients
Belinda Jiao
Princess Margaret Cancer Centre
Project: Comparison of Utilizing Real-time AI and human Techniques for data Extraction in ONCology (CURATE-ONC)
Berenice Urtecho
Princess Margaret Cancer Centre
Project: RELIaNCE: Radiomic and gEnomic modeLing to predIct recurreNCe in Early lung cancer
Calvin Chan
Lunenfeld-Tanenbaum Research Institute
Project: Enabling Cancer Biomarker Discovery with Mass Spectrometry-based Plasma Proteomics
Carlos Diego Holanda Lopes
Princess Margaret Cancer Centre
Project: Bacteria-Derived Blood Metabolites as Surrogates of Microbiome Diversity and Outcomes in Metastatic Melanoma on Immunotherapy
Catherine Weadick
Princess Margaret Cancer Centre
Project: Desmoid Quality of Life and Outcomes Study (DeQoL Study)
Catrian Sotelo
Hospital for Sick Children
Project: From Voices to Disclosure Timing: Towards Patient-Centered Guidelines for Communicating Cancer Predisposition in Pediatrics
Charles Tan
Princess Margaret Cancer Centre
Project: Diagnostic Accuracy of Virtual Programmed Death Ligand-1 (PD-L1) Immunohistochemistry in Head and Neck Squamous Cell Carcinoma using Artificial Intelligence
Chloe Gui
Toronto Western Hospital
Project: Single-cell lineage tracing in plexiform neurofibromas and malignant peripheral nerve sheath tumours to assess intra-tumoral heterogeneity and mechanisms of drug resistance
Christopher Lozano
St. Michael's Hospital
Project: Incidence, Reoperation, and Survival in Primary Intradural Spinal Tumors: A Population-
Based Study in Ontario
Clara Bonnet
Lunenfeld-Tanenbaum Research Institute
Project: Deciphering CIP2A-dependent DNA damage tolerance during cell division
Clarissa Skorupski
Princess Margaret Cancer Centre
Project: Evaluating the Impact of Transfusions on the Quality of End of Life Care for Patients with
Myelodysplastic Syndromes (MDS)
Dana Rosenberg
Toronto Western Hospital
Project: A Prospective Cohort Study of Adults with Rheumatic Immune Related Adverse Events associated with Cancer Immunotherapies
Danielle Arshinoff
Toronto General Hospital
Project: Linking Consensus Molecular Subtypes to the Tumor Immune Microenvironment in Biliary Tract Cancer
Darius Ashrafi
Sunnybrook Health Sciences Centre
Project: Incidence of Subsequent Primary Malignancies After Immune Checkpoint Inhibitor Therapy for Metastatic Renal Cell Carcinoma: A Population-Based Study
David-Dan Nguyen
Princess Margaret Cancer Centre
Project: Enhancing equity and mitigating overdiagnosis of prostate cancer through the development and evaluation of machine learning-driven organized prostate cancer screening policies
Deanna Ng
Sinai Health System
Project: A precision-medicine approach to management of Retroperitoneal Liposarcoma (RP LPS) informed by radiomic and genomic analyses
Derek Chan
Hospital for Sick Children
Project: Functional mapping of somatic genetic rescue pathways in DNAJC21-related bone marrow failure and leukemia predisposition
Duhita Sengupta
Hospital for Sick Children
Project: Advancing Towards a Chemo-Free Era in Pediatric & Young Adults with Low-Grade Glioma (pLGG)
Erin T. Hamanishi
Hospital for Sick Children
Project: Impact of Post-Immunotherapy Curie Scores on Outcomes in High-Risk Neuroblastoma Patients
Fernando Pikabea Díaz
Princess Margaret Cancer Centre
Project: Ultrasensitive ctDNA Detection for Minimal Residual Disease (MRD) Assessment in Early-Stage NSCLC: A Perioperative Analysis from the ctDNA Lung DETECT Study
Giorge Voutsas
Lunenfeld-Tanenbaum Research Institute
Project: Transforming Palliative Care for People Living with Advanced Cancer: Developing a Pan-Canadian Research Platform
Haydee Williams Sanchez
Princess Margaret Cancer Centre
Project: Analyzing Microbiome Dynamics as Biomarkers to Guide Treatment Selection in Intermediate-Risk HPV-Positive Oropharyngeal Carcinoma
Helena (Ellen) Janse van Rensburg
Princess Margaret Cancer Centre
Project: Characterization of oligometastatic and metastatic ER+ breast cancer detected through ctDNA surveillance
Irem Yenidogan
Hospital for Sick Children
Project: Personalizing Immunotherapy for Pediatric MMRD-HGG: From Biomarkers to Bedside
Isaac Kong
Sunnybrook Health Sciences Centre
Project: The individualization of radical radiation treatment with the use of intra-treatment 2-(F-18) Fluoro-2-Deoxy-D-Glucose (FDG) positron emission tomography in advanced head and neck cancer
Italo Fernandes
Sunnybrook Health Sciences Centre
Project: Variation in healthcare utilization and costs by facility type among Ontario patients treated with immune checkpoint inhibitors between 2017 and 2022
Jasleen Saini
St. Michael's Hospital
Project: The Impact of Adjuvant Radiation Therapy on Survival in Skull Base and Spinal Chondrosarcoma: A Population-Based Cohort Study
Jean Henri Maselli Schoueri
Princess Margaret Cancer Centre
Project: Metabolic Conditioning for Immunotherapy: Exercise-Driven Modulation of α-Hydroxybutyrate and Outcomes in Melanoma Treated with Ipilimumab–Nivolumab
Justin Panasci
Princess Margaret Cancer Centre
Project: Seeing the Unseen: Harnessing Inferred Transcriptomics from Routine Pathology to Predict Durable Immunotherapy Response in Head and Neck Cancer
Kai Yang
Lunenfeld-Tanenbaum Research Institute
Project: Al Guided Synthetic Lethality Prediction for Cancer Target Discover
Karine Ronan
Princess Margaret Cancer Centre
Project: Using Co-Design to Extend the Equitable Reach of Knowledge Mobilization to Support Exercise Recommendations in People with Bone Metastases
Laura Venegas
Princess Margaret Cancer Centre
Project: Investigating the Role of PFAS and Other Environmental Chemicals in the Risk of Developing Gynecological Cancer (BioRisk Program)
Linshan Liu
Lunenfeld-Tanenbaum Research Institute
Project: Mapping the Epigenetic Dynamics of Revival Stem Cells to Overcome Colorectal Cancer Therapy Resistance
Luciana Beatriz Mendes Gomes Siqueira
Princess Margaret Cancer Centre
Project: Understanding the association between emotional distress, interferon signature, and outcomes among cancer patients receiving immune checkpoint inhibitors
Lucshman Raveendran
Princess Margaret Cancer Centre
Project: A prospective feasibility randomized controlled trial of focal therapy versus active surveillance for MRI-Visible Gleason Grade Group 1 prostate cancer
Maria Antonia Gomez-Sierra
Sinai Health System
Project: Exploring the potential for YAP/TAZ targeting as a novel therapy in myxoid liposarcoma
Marissa Solow
St. Michael's Hospital
Project: Technology in Cancer Care; Examining the impact of IT in Cancer Care Delivery at St Michael’s Hospital
Mike Hart-Matyas
Hospital for Sick Children
Project: Development of a CAR NK cell platform for delivery of gene editors to AML to mediate oncogene knock-out and killing
Mithunan Ravindran
Sunnybrook Health Sciences Centre
Project: A Dynamic Machine Learning Model of Critical Care Utilization and Post-Critical Care Outcomes in Patients with Hematologic Malignancies
Natasha Barone
Hospital for Sick Children
Project: Informed Decisions for Small Patients: Development of a Surgical Decision Framework for Children with Lower Limb Bone Sarcoma
Paula Isabel Gimena Franco
Princess Margaret Cancer Centre
Project: My Peer Alliance Linkage (MyPAL) Trial – a Single-Center Phase 2 Open-label Trial on the Effectiveness of One-on-one Peer Mentoring for Adolescent and Young Adult (AYA) Patients with Cancer
Peiran Sun
Princess Margaret Cancer Centre
Project: Molecular Residual Disease Detection using Circulating Tumour DNA in Resected Gastroesophageal Carcinoma
Peter Donato
Princess Margaret Cancer Centre
Project: Phase 0 Pilot Study of ^177Lu-FAPI in Advanced Metastatic Urothelial Carcinoma
Raman Sambhi
Sunnybrook Health Sciences Centre
Project: Plasma hepcidin as a prognostic biomarker in early breast cancer: a post-hoc assessment in the MA.32 randomized clinical trial
Rawy Shaaban
Princess Margaret Cancer Centre
Project: Clinical Outcomes of 3 Versus 4 Fractions of Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: A Multi-Institutional Analysis
Rich Ericson King
Princess Margaret Cancer Centre
Project: Gut microbiome composition and the influence of antibiotic therapy on outcomes and toxicities in localized aerodigestive cancers: a prospective translational study
Ruxandra Mitre
Princess Margaret Cancer Centre
Project: The impact of clonal hematopoiesis on gastroesophageal cancer outcomes
Smadar Bauer
Princess Margaret Cancer Centre
Project: Interrupting the Earliest Steps of High Grade Serous Ovarian Cancer: A Pharmacologic Prevention Platform for BRCA Carriers
Suman Gopal Ghosh
Sunnybrook Health Sciences Centre
Project: Machine Learning Oncotype Prediction from Quantitative Ultrasound Breast Tumour Data
Sun-Hye Ko
Princess Margaret Cancer Centre
Project: Development of a Prognostic Model for Treatment Response and Survival in Patients with Hairy Cell Leukemia in the Era of Targeted Therapy
Tatiana Ugalde Catarinella
Princess Margaret Cancer Centre
Project: Multi-center evaluation of DPYD genotyping prior to fluoropyrimidine chemotherapy: adoption and impact
Vishwathsen Karthikeyan
St. Michael's Hospital
Project: Practice Patterns and Outcomes Related to Time to Adjuvant Radiation After Surgery for Metastatic Spinal Tumors: A Population-Based Cohort Study
Vladimir Djedovic
Princess Margaret Cancer Centre
Project: A translational prospective study assessing the intestinal microbiome constitution and its relationship with the efficacy of anticancer therapies and prevalence of related toxicities as a novel conceptual biomarker-finding model in gastroesophageal tumors and matched household controls
Walther Brochier
Princess Margaret Cancer Centre
Project: Targeting ANKS3 to improve CAR-T response in renal medullary carcinoma
Xiaoyang (Kevin) Lan
Princess Margaret Cancer Centre
Project: Impact of clonal hematopoiesis on relapse risk after curative intent treatment for hepatocellular carcinoma
Yael Goldberg
Princess Margaret Cancer Centre
Project: Gene discovery – identification of genetic variants associated with inherited pancreatic cancer
Yosef Ellenbogen
Toronto Western Hospital
Project: Dissecting the Determinants and Dynamics of Cellular States Promoting Glioma Evolution
Abdullah Ishaque, Toronto Western Hospital
Project: Three-dimensional radiomic analysis of meningiomas
Ahmad Mousa, Princess Margaret Cancer Centre
Project: Primary Retroperitoneal Lymph Node Dissection in Marker Positive Clinical Stage II Testicular Cancer
Alberto Riojas Garza, Sinai Health System
Project: Long-term outcomes following resection of colorectal liver metastases: development of a predictive model
Alessandra Borghi, Sinai Health System, CentreCourt Hold’em for Life Oncology Fellow
CentreCourt Hold’em for Life Oncology Fellow
Project: Moving the needle in Retroperitoneal Sarcoma surgical management: Towards an international consensus on optimal operative approach
Armaan Malhotra, St. Michael's Hospital
Project: Quantifying the personal and spousal impact of primary intracranial tumor diagnosis on employment and income for working Canadians
Arman Zereshkian, Princess Margaret Cancer Centre
Project: Use of Bone Targeting Agents (BTAs) in patients with metastatic castrate resistant prostate cancer (mCRPC) and bone metastases receiving standard of care radioligand therapy at Princess Margaret Cancer Center (PM)
Beatriz Anton Pascual, Princess Margaret Cancer Centre
Project: HOPES program - Helping early-onset GI-patients experience and survivorship
Berenice Urtecho, Princess Margaret Cancer Centre
Project: Lung Cancer EGFR, ALK, and ROS1 Detection using Digital Pathology and DEep LeaRning (LEADER)
Carlos Diego Holanda Lope, Princess Margaret Cancer Centre
Project: Circulating Active Chromatin Detection as a Predictive Marker for Response to ICI-based Therapy in Metastatic Leiomyosarcoma Patients
Catia Gaspar, Princess Margaret Cancer Centre
Project: Genomic, transcriptomic and clinicopathological predictors of early vs late recurrence after curative intent surgery in patients with pancreatic cancer
Changsu Par, Princess Margaret Cancer Centre
Project: Selecting Patients for Immunotherapy in Renal Cell Carcinoma Employing Artificial Intelligence (SPIRE-AI)
Chieh-Ting (Jerry) Fang, Lunenfeld-Tanenbaum Research Institute
Project: Investigating the proteostatic roles of PCNT-HSP70-PCM1 axis in centrosome-amplified breast cancer cells
Chloe Gui, Toronto Western Hospital
Project: Single-cell lineage tracing in plexiform neurofibromas and malignant peripheral nerve sheath tumours to assess intra-tumoral heterogeneity and mechanisms of drug resistance
Clare O'Connell, Princess Margaret Cancer Centre
Project: Association of cumulative exposure to Glucagon-like peptide-1 (GLP-1) agonists with Prostate Cancer Incidence and Outcomes: A Population-Based Analysis
Dana Narvaez, Princess Margaret Cancer Centre
Project: ctDNA Dynamics and Response with Endocrine therapy and palbociclib, Monitoring in the MA38 trial (ctDNA DREaM MA.38)
Dana Rosenberg, Toronto Western Hospital
Project: A Prospective Cohort Study of Adults with Rheumatic Immune Related Adverse Events associated with Cancer Immunotherapies
David-Dan Nguyen, Princess Margaret Cancer Centre
Project: Enhancing equity and mitigating overdiagnosis of prostate cancer through the development and evaluation of machine learning-driven organized prostate cancer screening policies
Deepro Chowdhury, Princess Margaret Cancer Centre
Project: CRUISE: A Prospective Trial of Circulating Tumour DNA-Guided Urothelial Carcinoma Treatment De-Intensification following Complete Tumour ResponSE.
Douglas Cheung, Princess Margaret Cancer Centre
Atrium/CMCC Hold’em for Life Oncology Fellow
Project: Seeing Clearly: A Decision Analysis of MRI, PSMA PET/CT, and Biomarker Testing in Early Prostate Cancer Detection
Elena Kunadis, Sinai Health System
Project: Clinical and Molecular Predictors of Treatment Response and Survival in Peritoneal Mesothelioma: A Real-World Study at a High-Volume Center
Elina Cook, Princess Margaret Cancer Centre
Project: Investigating the role of inflammation-related genetic mechanisms in radiation toxicity
Eric Stutheit-Zhao, Princess Margaret Cancer Centre
Project: ACT-NIMBly: Accelerating Clinical Translation of Non-invasive Imaging and Molecular Biomarkers
Erick Saldanha, Princess Margaret Cancer Centre
Project: Simultaneous cell-free whole genome and epigenome sequencing to detect molecular residual disease in high-risk melanoma using liquid biopsy
Gregoire Marret, Princess Margaret Cancer Centre
Project: A Machine Learning Framework to Predict Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma Using Spatial Transcriptomics
Inna Gong, Princess Margaret Cancer Centre
Project: Biomarker development and optimization of chimeric antigen T cell receptor therapy for lymphoma
Jaime Godoy Santin, Sunnybrook Health Sciences Centre
Project: A phase 2 trial for elderly patients with newly diagnosed glioblastoma and unmethylated MGMT promoter.
Jin-Soo Park, Toronto General Hospital
Project: Neoadjuvant ImmunOtherapy and Non-ablative Oligofractionated Radiation Therapy for upfront resectable gastroesophageal cancer – NIO-NORT Trial"
Jonathan Sen, Toronto General Hospital
Project: Leveraging Population Genomics to Predict Cardiotoxicity from Cancer Therapy
Julien Dessapt, Lunenfeld-Tanenbaum Research Institute
Project: Investigating the molecular vulnerabilities of Notch-mutant HNSCCs
Karen Arane, Hospital for Sick Children
Project: Long-term outcomes of neuroblastoma survivors: A population-based study in Ontario, Canada
Karine Ronan, Princess Margaret Cancer Centre
Project: Acceptability, Appropriateness, and Utility of an Online Decision Tool (The Exercise in Cancer Evaluation and Decision Support algorithm; EXCEEDS) to Support Adults Moving Through Cancer
Kate Murphy, Sunnybrook Health Sciences Centre
Project: Facilitating cascade testing in BRCA1/2 pathogenic mutation carriers via a digital tool and assessing user experience
Kevin (Xin) Wang, Princess Margaret Cancer Centre
Project: Histomic integration with multi-omic data for massively scalable precision oncology
Laura Raiti, Hospital for Sick Children
Project: Exploring the early genetic determinants of tumour risk in Li-Fraumeni syndrome
Leeor Yefet, Toronto Western Hospital
Project: A Phase 0 Clinical Trial of Vorinostat for Patients with Recurrent Meningioma
Marina Dutra, Hospital for Sick Children
Project: Methylation profiling in Wilms tumor: a link between constitutional genetics and tumor phenotype
Mercedes Herrera Juare, Princess Margaret Cancer Centre
Project: Landscape Mapping of Epitopes and T Cell Receptors for Malignant Pleural Mesothelioma (MESO-LANDMARC)
Mohammad Jay, Sunnybrook Health Sciences Centre
Project: Evaluating Risk Factors for Long-Term Complications of Post-Surgical Treatments in Adults with Differentiated Thyroid Cancer
Nadia Ghazali, Princess Margaret Cancer Centre
Project: Real-world evidence of cabozantinib as second-line treatment for radioiodine-refractory differentiated thyroid cancer: single centre analysis
Neha Pathak, Princess Margaret Cancer Centre
Project: Evaluating the barriers and facilitators of a referral to the cancer rehabilitation and survivorship program for older adults with cancer: a mixed methods study
Peter Donato, Princess Margaret Cancer Centre
Project: FAPI and FDG PET for Advanced Urothelial Carcinoma Staging
Rich Ericson King, Princess Margaret Cancer Centre
Project: Role of microbiome as a marker of response, immune profiles, and toxicities in aerodigestive tumors: a translational prospective study
Richa Jaiswal, Women's College Hospital
Project: Population-based retrospective, observational cohort study on disparities in breast cancer screening, incidence, clinical presentation, treatment and survival outcomes among immigrant women in Ontario, Canada
Rintu Sharma, Princess Margaret Cancer Centre
Project: Development of a Prognostic Model for Treatment Response and Survival Outcomes for patients with Relapsed Refractory Multiple Myeloma receiving BCMA-directed Bispecific Antibody Therapy
Ronan McLaughlin, Princess Margaret Cancer Centre
Project: ADaptive Organoid-Based Precision Therapy Study in Pancreatic Cancer (ADOPT) – A Phase II singlearm study to evaluate the efficacy of Patient-Derived Organoid (PDO)-directed therapy in advanced Pancreatic Ductal Adenocarcinoma (PDAC)
Ruben Del Castillo, Sunnybrook Health Sciences Centre
Project: Defining Subgroups of Patients with Intermediate Risk Prostate Cancer for Whom Active Surveillance is Safe
Sheeraz Ali, Princess Margaret Cancer Centre
Project: To assess clonal hematopoiesis as a risk factor for early onset colorectal cancer
Sheharzad Mahmood, St. Michael's Hospital
Project: Social Determinants of Health and Cancer Outcomes in Ontario
Terence Tang, Sunnybrook Health Sciences Centre
Project: Quantifying Osteosarcopenia and Spinal Deformity after Stereotactic Spine Radiotherapy and their Relationship to Musculoskeletal Functional Outcomes
Tian Xiao, Princess Margaret Cancer Centre
Project: Real-World Treatment Outcomes of Dabrafenib and Trametinib (D+T) in Advanced BRAF V600E-mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer (RAIRDTC)
Tiana Kordbacheh, Princess Margaret Cancer Centre
Project: CYTO-CAR: Investigating prolonged cytopenias in patients receiving CAR T-cell therapy
Ugo Dionne, Lunenfeld-Tanenbaum Research Institute
Project: Kinase translocations in cancer: commonalities and difference in mechanisms of action
Yibo Xuo, Lunenfeld-Tanenbaum Research Institute
Project: Charting CIP2A-TOPBP1-mediated DNA damage response during cell division
Yosef Ellenbogen, Toronto Western Hospital
Project: Dissecting the Determinants and Dynamics of Cellular States Promoting Glioma Evolution
Zachary Coyne, Princess Margaret Cancer Centre
Project: Lung Track: Circulating Tumor DNA for Post-Treatment Surveillance in Early-Stage NSCLC
Zemin Zhang, Lunenfeld-Tanenbaum Research Institute
Project: Targeting CRAF for degradation by the CTLH E3 ligase subunit GID4
Alexandra Acher, Sunnybrook Health Sciences Centre
Project: Histology-Based Radiomics Modeling – Can It Improve Preoperative Assessment of Locoregional Disease in Patients with Pancreas, Biliary, and Liver Cancer?
Said Ahmed Mohammed Al Saifi, Sunnybrook Health Sciences Centre
Project: A phase II trial of stereotactic body radiation therapy (SBRT) for selected stage II or III NSCLC patients ineligible for surgery or radical chemoradiation
Tatianny Araujo Vargas, Sunnybrook Health Sciences Centre
Project: Rare Mutation Melanoma Trial with Encorafenib and Binimetinib
Anouk Benseler, Sunnybrook Health Sciences Centre
Project: Ovarian function and fertility outcomes after oncologic immunotherapy: a population study
Fernando Binder, Mount Sinai Hospital
Project: Life-Threatening Complications of Chimeric Antigen Receptor T-Cell Therapy
Josh Bleicher, Princess Margaret Cancer Centre
Project: Patients’ perceptions of quality-of-life following surgical treatment of advanced peritoneal surface malignancies: a mixed methods study
Adom Bondzi-Simpson, Sunnybrook Health Sciences Centre
Project: Integrating Equity into Quality Metrics for Colorectal Cancer Care: An Analysis of Wait Times for Curative-Intent Surgery
Karanbir Brar, Toronto General Hospital
Project: Defining distinct molecular subtypes of esophageal adenocarcinoma for targeted therapy
Rubens Copia Sperandio, Sunnybrook Health Sciences Centre
CBRE Hold’em for Life Oncology Fellow
Project: Biomarker testing and its implications on treatment responses in advanced prostate cancer patients in a real-world setting
Zachary Coyne, Princess Margaret Cancer Centre
Project: Accelerating Time to Molecular Diagnosis in Early Lung Cancer (AToM)
Ugo Dionne, Lunenfeld-Tanenbaum Research Institute
Project: Kinase translocations in cancer: commonalities and differences in mechanisms of action
Marina Dutra, Hospital for Sick Children
Project: Methylation profiling in Wilms tumor: a link between constitutional genetics and tumor phenotype
Yosef Ellenbogen, Toronto Western Hospital
Project: Dissecting the determinants and dynamics of cellular states promoting glioma evolution
Mitchell Elliot, Princess Margaret Cancer Centre
Project: Acquired pharmacologic vulnerabilities in cyclin dependent kinase 4/6 inhibitor-resistant metastatic estrogen receptor positive breast cancer
Kevin Fan, Sunnybrook Health Sciences Centre
Project: Clinical, dosimetric and pathological biomarkers associated with development of brain metastases in an international multi-institutional cohort of patients treated with metastasis-directed therapy for oligometastatic disease
Italo Fernandes, Sunnybrook Health Sciences Centre
Project: MRI screening for brain metastases among patients with HER2+ stage II or III breast cancer: A multi-centre, single arm phase II clinical trial
Mark Freeman, Sunnybrook Health Sciences Centre
Project: Noninvasive Prediction of HER2 Status of Breast Cancer Brain Metastases with Deep Neural Networks”
Vikas Garg, Princess Margaret Cancer Centre
Project: Engaging ER pathway in Gynecologic Cancers
Inna Gong, Princess Margaret Cancer Centre
Project: Biomarker Development and Optimization of Chimeric Antigen Receptor T-cell Therapy for Lymphoma
Galileo Gonzalez, Princess Margaret Cancer Centre
BMO Hold’em for Life Oncology Fellow
Project: Characterizing the Genomic Landscape of Locally Advanced Pancreatic Cancer
Chloe Gui, Toronto Western Hospital
Project: Single-cell lineage tracing in plexiform neurofibromas and malignant peripheral nerve sheath tumors to assess tumoral heterogeneity and mechanisms of drug resistance
Gopila Gupta, Princess Margaret Cancer Centre
Project: Association of Markers of Inflammation with Clinical Outcomes in Patients with Myeloproliferative Neoplasms (MPNs)
Mathew Hall, Princess Margaret Cancer Centre
Project: A Mixed Methods Analysis of Access to Comprehensive Genomic Profiling Among Lung Oncologists in Ontario
Mercedes Herrera Juarez, Princess Margaret Cancer Centre
Project: Landscape Mapping of Epitopes and T Cell Receptors for Malignant Pleural Mesothelioma (MESO-LANDMARC)
Coralea Kappel, Princess Margaret Cancer Centre
Project: Cardio-oncology referral practices, knowledge, barriers, and facilitators of concordant care in breast cancer
Niranjan Khaire, Princess Margaret Cancer Centre
Project: Investigation of hematopoietic stem cell molecular signatures for predicting Clinical Outcomes of Allogeneic Stem Cell Transplant Recipients
Jeongseok Kim, Mount Sinai Hospital
Project: Characterization of the Tumor Microenvironment of Ulcerative Colitis-associated Colorectal Neoplasia with Imaging Mass Cytometry
Alexander Landry, Toronto Western Hospital
Project: A multi-omic approach to radiation resistance in meningioma
Jennifer Leigh, Mount Sinai Hospital
CentreCourt Hold’em for Life Oncology Fellow
Project: Gynecologic Symptoms of Menopause (GSM) During Treatment with Endocrine Therapy: Understanding the Incidence and Impact on Quality of Life in Patients with Breast Cancer
Yuchen Li, Princess Margaret Cancer Centre
Project: IMPROVE (Intelligent Modeling for Predicting and Reducing Overutilization of Visits to the
Emergency departments)
Ronan McLaughlin, Princess Margaret Cancer Centre
Project: A pan-tumor translational prospective study to characterize the intestinal microbiome constitution, and its relationship with the response to anticancer-therapies, related toxicities and the immune profile of these tumors as a novel conceptual biomarker finding model in gastrointestinal, hepatobiliary and non-small cell lung tumors
Karim Mithani, Sunnybrook Health Sciences Centre
Project: Breaking the Barrier: Focused Ultrasound-Mediated Delivery of Doxorubicin in Treating Pediatric Diffuse Intrinsic Pontine Gliomas
Ahmad Mousa, Princess Margaret Cancer Centre
Project: Retroperitoneal Lymph Dissection for Metastatic Nonseminomatous Germ Cell Tumors: Review of Oncologic Outcomes and the Role of Adjuvant Chemotherapy
Carlos Muzlera, Princess Margaret Cancer Centre
Project: Development and Validation of a Medical Oncology Workforce Planning Model in Ontario
Yoshiko Nakano, Hospital for Sick Children
Atrium/CMCC Hold’em for Life Oncology Fellow
Project: Pediatric cancer predisposition - More effective and less invasive approaches
Inbar Nardi Agmon, Toronto General Hospital
Project: Personalized Medicine in Cardiology-Oncology: Utilizing the gut microbiome and circulating metabolites to predict risk: A Pilot Prospective Cohort Study
David Nguyen, Princess Margaret Cancer Centre
Project: Enhancing patient care for 2SLGBTQ+ individuals through implementation for 2SLGBTQ+ cultural competency training for medical oncologists
David-Dan Nguyen, Princess Margaret Cancer Centre
CMCC/Atrium Hold’em for Life Oncology Fellow
Project: Enhancing equity and mitigating over-diagnosis of prostate cancer through the development and evaluation of machine learning-driven organized prostate cancer screening policies
Daniel Palhares, Sunnybrook Health Sciences Centre
Project: Diffusion Magnetic Resonance Imaging to Detect Adversely Prognostic Tumour Regions in Glioblastoma Patients Undergoing Adaptive Magnetic Resonance-Guided Radiotherapy
Neha Pathak, Princess Margaret Cancer Centre
Project: Using the Cancer Aging and Research Group- Breast Cancer (CARG-BC) predictive model in older adults with early breast cancer: an external validation study
Renee Potashner, Hospital for Sick Children
Project: A Pilot Project to Implement a Digital Comprehensive Psychosocial Screening Tool in Paediatric Oncology
Harkanwal Randhawa, Princess Margaret Cancer Centre
Project: Long-term outcomes of active surveillance for patients with Gleason grade group 2 prostate cancer
Faisal Rashed, Lunenfeld-Tanenbaum Research Institute
Project: Delineating the role of CIP2A-TOPBP1 complex in processing mitotic DNA lesions
Tayler Declan Ross, Sunnybrook Health Sciences Centre
Project: Quantifying Osteosarcopenia Progression with Imaging Biomarkers in Prostate Cancer
Catherine Sarre, Mount Sinai Hospital
Project: Adult soft tissue sarcomas in Mexico: Current patterns of presentation, treatment, and oncologic outcomes
Noor Shakfa, Lunenfeld-Tanenbaum Research Institute
National Bank Hold’em for Life Oncology Fellow
Project: Investigating tumour immune multi-cellular environments to inform therapy selection in pancreatic cancer
Husain Shakil, St. Michael's Hospital
Project: Longitudinal Population-Based Study Investigating Changes in the Epidemiology and Treatment-Related Outcomes of Patients with Spinal Metastases
Pamela Denisse Soberanis Pina, Princess Margaret Cancer Centre
Project: Impact of HPV DNA integration in Cervical Cancer (VEN-HPV)
Jennifer Spiegel, Sunnybrook Health Sciences Centre
Project: Intratympanic N-Acetylcysteine (NAC) injections for prevention of cisplatin-induced ototoxicity in head and neck cancer patients: A multi-centre phase I/II randomized controlled trial.
Scott Strum, Princess Margaret Cancer Centre
Project: Deciphering circulating tumor DNA signatures of primary versus acquired resistance to immunotherapy in advanced cancer patients
Adam Suleman, Princess Margaret Cancer Centre
Project: Assessing the Impact of Marginalization on Outcomes for Patients Undergoing Autologous and Allogeneic Stem Cell Transplantation
Noémie Villemure-Poliquin, Sunnybrook Health Sciences Centre
Project: Treatment Delays in Head & Neck Cancers: A Mixed Methods Study
Catherine Weadick, Princess Margaret Cancer Centre
Project: Radiomics in Gastrointestinal Stromal Tumor (RING) Study
Marian Severin Wettstein, Princess Margaret Cancer Centre
Project: Trimodal Therapy versus Radical Cystectomy for Muscle-Invasive Bladder Cancer: Emulation of a Randomized Controlled Trial Using Observational Data
Talya Wittmann Dayagi, Hospital for Sick Children
Project: Short and long-term outcomes of patients with inherited bone marrow failure syndromes (IBMFS) with and without hematopoietic stem cell transplantation (HSCT): A population-based pan-Canadian cohort study
Tian Xiao, Princess Margaret Cancer Centre
Project: Treatment and Outcomes of Advanced Thyroid Cancer in the Elderly and Frail Population
Alice Zhu, Sunnybrook Health Sciences Centre
Project: Developing a Personalized Model to Predict Symptom Burden in Patients with Gastrointestinal Malignancies
Anudari Zorigtbaatar, Toronto General Hospital
Project: Understanding inequities in HCC cancer care from a comparative health systems perspective
Tatianny Paula Araújo Vargas, Sunnybrook Health Sciences Centre
Project: Rare Mutation Melanoma Trial with Encorafenib and Binimetinib
Carly Barron, Princess Margaret Cancer Centre
Project: Cross tumor-comparison of the tumor immune microenvironment, peripheral immune signatures and response to immunotherapy as a novel conceptual model in aerodigestive tumors
Edward Chen, Lunenfeld-Tanenbaum Research Institute
Project: Immune Modulation in Hippo Pathway Regulated Breast Tumour Microenvironments
Massimo Di Iorio, Princess Margaret Cancer Centre
Project: Exercise and Rehabilitation for People with Cancer: A Survey of Canadian Oncology Residents’ Knowledge and Awareness of Practice Guidelines
Nely Mercy Díaz Mejía, CBRE Hold'em for Life Fellow, Princess Margaret Cancer Centre
Project: A retrospective review of the use of GCSF for patients with GU receiving chemotherapy during the COVID-19 pandemic and implications for the future
Mitchell Elliot, Princess Margaret Cancer Centre
Project: Acquired pharmacologic vulnerabilities in cyclin dependent kinase 4/6 (CDK4/6) inhibitor-resistant hormone receptor positive breast
Ian Hirsch, Princess Margaret Cancer Centre
Project: Profiling of Cancer of Unknown Primary Site, Melanoma, Adnexal, Skin for Optimizing Immunotherapy
Thomas Kennedy, Sunnybrook Health Sciences Centre
Project: Detection of Circulating Tumour DNA before and after Stereotactic Ablative Radiotherapy for Confirmed and Suspected Early Lung Cancer (SABR-DETECT)
Colleen Kerrigan, Sunnybrook Health Sciences Centre
Project: Reflex MammaPrint and BluePrint testing on breast cancer core biopsies: Impact on tumor phenotype classification, perceived provider utility, and process implementation
Jethro Kwong, Silvercore Hold'em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Development of an early warning system for non-muscle invasive bladder cancer recurrence and progression using time-series forecasting with artificial intelligence
Diego Malon Gimenez, Princess Margaret Cancer Centre
Project: Incidence, prevalence, risk factors and impact of fatty liver disease in metastatic HR+/HER2− breast cancer patients in first line of treatment with Aromatase Inhibitors and CDK 4/6
Amy Lu, The Hospital for Sick Children
Project: Describing limited English proficiency (LEP) in paediatric oncology
Adi Nitzan-Luques, The Hospital for Sick Children
Project: Translational in vivo modeling to identify therapeutic opportunities for high-risk neuroblastoma
Daniel Palhares, Sunnybrook Health Sciences Centre
Project: Stimulated Microbubble Radiation Enhancement Treatment in Head and Neck Cancer Patients
Jenny Peng, Princess Margaret Cancer Centre
Project: Understanding the gene expression profile of neuroendocrine carcinoma of genitourinary primaries: a pilot study
Erick Saldanha, Princess Margaret Cancer Centre
Project: Use of targeted therapies in patients with advanced thyroid cancer: efficacy and safety outcomes from a real-world genomically profiled cohort
Marie-Philippe Saltiel, Princess Margaret Cancer Centre
Project: Improving the Transition to Practice Curriculym in the Medical Oncology Training Program
Amit Sharma, Lunenfeld-Tanenbaum Research Institute
Project: Deciphering the role of the Formin / Wnt-PCP axis in breast cancer cell motility and Metastasis
Mariska Sie, The Hospital for Sick Children
Project: DNA-damage response targeting and epigenetic priming to overcome radio-resistance in very high-risk medulloblastoma
Ana Veneziani, Princess Margaret Cancer Centre
Project: Phase I Study of Autologous Epithelial Ovarian Cancer (EOC) Cells Containing Lentivirus Engineering Expression of IL-12
Kevin Wang, Princess Margaret Cancer Centre
Project: Comprehensive genomic, immunologic and metabolomic characterization of the tumour, host, and gut microbiome interaction in hepatocellular carcinoma
Justin Wang, Toronto Western Hospital
Project: Uncovering the epigenetic and transcriptomic biomarkers of response to radiotherapy in meningiomas
Yibo Xue, Lunenfeld-Tanenbaum Research Institute
Project: Studying DNA damage networks in human cancer cells
Rui Miguel Marques Bernardino, Princess Margaret Cancer Centre
Project: Unravelling the potential of extracelular vesicles as biomarkers of intraductal and cribriform prostate cancer
Adom Bondzi-Simpson, Sunnybrook Health Sciences Centre
Project: Integrating equity into quality metrics for colorectal cancer care: an Analysis of wait times for curative-intent surgery
Sanjeev Budhathoki, Lunenfeld-Tanenbaum Research Institute
Project: Development of risk prediction models for early detection and prognosis of aerodigestive cancers
Alberto Hernando Calvo, Princess Margaret Cancer Centre
Project: External validation of the VIGEX gene-expression signature as a novel predictive biomarker for immuno-oncology (IO) treatments
Julian Chavarriaga, Princess Margaret Cancer Centre
Project: miRNAs as potential circulating tumor markers for stratifying and surveilling small testicular masses
Rania Chehade, Sunnybrook Health Sciences Centre
Project: Toward Immunotherapy in breast cancer brain metastases: PD-L1 expression and beyond
Danielle Cuthbert, Princess Margaret Cancer Centre
Project: Process Analysis for the HIMALAYAS Study: Cancer Survivor's Experience with a Supervised Cardio-Oncology Rehabilitation Program
David Cyr, Mount Sinai Hospital
Project: Enhancing Prognostication in Colorectal Cancer: the Role of Clinico-pathologic and Molecular Features Beyond the TNM Staging System
Anirban Das, The Hospital for Sick Children
Project: Gliomas with DNA-replication repair deficiency: How the cell-of-origin, genomic, and epigenetic landscape impact immune-directed therapeutic vulnerability
Ahmed Elmotayam, Lunenfeld-Tanenbaum Research Institute
Project: A New Therapeutic Strategy for Highly Lethal Small Cell Neuroendocrine Cancers
Abdul Rehman Farook, Princess Margaret Cancer Centre
Project: Cancer cachexia and genotype correlations in Pancreatic Ductal Adenocarcinoma
Jesus Fuentes Antras, Princess Margaret Cancer Centre
Project: Tumor-informed ctDNA dynamics in HR+/HER2- metastatic breast cancer patients receiving first-line CDK4/6 inhibitors
Sofia Genta, Princess Margaret Cancer Centre
Project: CP-101 and Atezolizumab in Patients with Advanced Solid TumorS to INterrogate the Gut Microbiota (CASSIN)
Maru Gete, Mount Sinai Hospital
Project: Molecular Testing of Indeterminate Thyroid Nodules for Informed Surgical Management
Samantha Hershenfeld, Princess Margaret Cancer Centre
Project: Clinico-genetic risk stratification of limited stage follicular lymphoma
Amanda Hird, Sunnybrook Health Sciences Centre
Project: Contemporary Risk of Bone Fractures Among Men with Advanced Prostate Cancer on Androgen Deprivation Therapy
Kyle Juraschka, The Hospital for Sick Children
Project: Harnessing CRISPR to identify drivers of medulloblastoma metastasis
Karineh Kazazian, Princess Margaret Cancer Centre
Project: Indocyanine green (ICG) Guided Sentinel Lymph Node Biopsy in Breast Cancer
Colleen Kerrigan, Sunnybrook Health Sciences Centre
Project: Reflex MammaPrint and BluePrint testing on breast cancer core biopsies: Impact on tumor phenotype classification, perceived provider utility, and process implementation
Ravi Kumar, Princess Margaret Cancer Centre
Project: Characterizing the impact of using novel patient-centered pathology reports in clinical practice
Jethro Kwong, Princess Margaret Cancer Centre
Project: Development of an early warning system for non-muscle invasive bladder cancer recurrence and progression using time-series forecasting with artificial intelligence
Lucy Ma, Princess Margaret Cancer Centre
Project: Next-Generation Sequencing in Advanced Thyroid Cancers: Clinical Application and Impact on Patient Outcomes
Louise McLoughlin, Princess Margaret Cancer Centre
Project: Explainable Artificial Intelligence in the diagnosis of Muscle Invasive Upper Tract Urothelial Carcinoma
Gordon Taylor Moffat, Princess Margaret Cancer Centre
Project: Optimizing the Quality of Surveillance in Patients with Completely Resected Gastroenteropancreatic Neuroendocrine Tumours
Consolacion Molto Valiente, Princess Margaret Cancer Centre
Project: Machine learning to estimate the real-world risk of 3-year disease free survival in patients with residual, triple negative breast cancer after neoadjuvant chemotherapy
Daniel Palhares, Sunnybrook Health Sciences Centre
Project: Pilot Investigation of Ultrasound Cell Death Imaging and Spectroscopy as Early Indicators of Response to Radiation Treatment in Prostate Cancer
Sabrina Piedimonte, Princess Margaret Cancer Centre
Project: Predicting Response to Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Using the Rate of Elimination of CA-125 (KELIM Score) and Chemo-Response Score
Nikhil Raghuram, The Hospital for Sick Children
Project: Targeting EZH2 in EBTs: Role of epigenetic modifiers in modulating pluripotency
Gabriel Revon-Riviere, The Hospital for Sick Children
Project: Characterization of MUC16/CA125 expression in pediatric in pediatric soft-tissue sarcomas and pilot study of a first-in-class MUC16/CA125 T-cell engager bispecific antibody
Enrique Sanz Garcia, Princess Margaret Cancer Centre
Project: Study of circulating tumor DNA (ctDNA) kinetics in immuno-oncology (IO-KIN)
Alina Selega, Lunenfeld-Tanenbaum Research Institute
Project: Detecting epithelial-mesenchymal transition states in highly multiplexed imaging data
Mariska Sie, The Hospital for Sick Children
Project: Epigenetic Priming to Overcome Radio-Resistance in Very High-Risk Medulloblastoma
Pavlina Spiliopoulou, Princess Margaret Cancer Centre
Project: Immune Response to COVID-19 Vaccine in immunotherapy (IO) and non-IO Treated Cancer Patients (VIVACIOUS)
Henry Miew Hoon Su, Toronto General Hospital
Project: Age Related Clonal Hematopoiesis and Atherosclerotic Cardiovascular Disease in Cancer Survivors
Michael S. Taccone, The Hospital for Sick Children
Project: Mitochondrial Fission: Targeting the Achilles’ Heel of Glioblastoma
Raj Vikesh Tiwari, Princess Margaret Cancer Centre
Project: Free/Total PSA ratio as a biomarker for PSMA PET positivity in patients with biochemical recurrence post prostatectomy
Randy Van Ommeren, The Hospital for Sick Children
Project: Characterization of the metabolic drivers of grp3 medulloblastoma metastasis
Richard Walker, Sunnybrook Health Sciences Centre
Project: Learning Curves and Volume-Outcome Relationships in Robot-Assisted Surgical Oncology
Irene Xie, Princess Margaret Cancer Centre
Project: Identifying molecular vulnerabilities in pancreatic ductal adenocarcinoma
Jeffrey Zuccato, Princess Margaret Cancer Centre
Project: Lung adenocarcinoma brain metastasis prediction and non-invasive diagnosis using methylation signatures in tissue and plasma
Marie Alt, Mount Sinai Hospital
Project: Optimizing Sexual Health and Emotional Well-Being got Breast Cancer Patients and Survivors
Federico Carini, Mount Sinai Hospital
Project: Venous thromboembolism in hematologic malignancy and hematopoietic cell transplant patients
Douglas Cheung, Princess Margaret Cancer Centre
Project: Seeing Clearly: A Decision Analysis of MRI, PSMA PET/CT, and Biomarker Testing in Early Prostate Cancer Detection
Sarah Cohen-Gogo, The Hospital for Sick Children
Project: PICTURE: PARP Inhibitors and Chemotherapy for patients harbouring TUmours with homologous REcombination repair deficiency: a phase II pilot study
David Cyr, Mount Sinai Hospital
Project: Clinicopathologic and Molecular Predictors of Outcomes Following Salvage Surgery for Locally Recurrent Rectal Cancer
Alexandra Desnoyers, Princess Margaret Cancer Centre
Project: Fragility Index of Approved Cancer Drugs
Grace Egan, Princess Margaret Cancer Centre
Project: Nuclear Hexokinase 2: Mechanism of Regulating Stemness in Acute Myeloid Leukemia
Robert Grant, Princess Margaret Cancer Centre
Project: Predicting Outcomes in Pancreatic Cancer from Clinical and Genomic Data using Machine Learning
Alexander Gregor, Toronto General Hospital
Project: Enhancing sentinel lymph node mapping in lung cancer surgery using a novel liposome-based dual-modality nanoparticle
Keegan Guidolin, Princess Margaret Cancer Centre
Project: Porphysomes for the intraoperative visualization of colorectal lymph node metastases
Dumas Guillaume, Mount Sinai Hospital
Project: The Impact of Critical Illness on Oncology Care Following Critical Care Survival
Fyeza Hasan, The Hospital for Sick Children
Project: Children with Cancer as Participants in End-of-life-Research
Kyle Juraschka, The Hospital for Sick Children
Project: Harnessing CRISPR to identify drivers of medulloblastoma metastasis
Kristen McAlpine, Princess Margaret Cancer Centre
Project: Comparison of OpeN VErsus RoboTic (CONVERT) Partial Nephrectomy Trial- a feasibility randomized control trial
Nick Meti, Princess Margaret Cancer Centre
Project: Machine Learning to estimate risk of 3-year disease-free survival in patients with residual, HER2-positive breast cancer after neoadjuvant chemotherapy and HER2- targeted therapy.
Randy Van Ommeren, The Hospital for Sick Children
Project: Characterization of the metabolic drivers of grp3 medulloblastoma metastasis
Michael Taccone, The Hospital for Sick Children
Project: Mitochondrial Fission: Targeting the Achilles' Heel of Glioblastoma
Abi Vijenthira, Princess Margaret Cancer Centre
Project: Application of the Generalizable Frailty Index using population-based health administrative data in older patients with diffuse large B-cell lymphoma (DLBCL), with further sensitivity analyses using a smaller cohort with detailed pathologic and cancer-specific data
Irene Xie, Princess Margaret Cancer Centre
Project: Identifying molecular vulnerabilities in pancreatic cancer
Marie Alt, Mount Sinai Hospital
Project: Optimizing Sexual Health and Emotional Well-Being got Breast Cancer Patients and Survivors
Zubair Bayat, Mount Sinai Hospital
Project: Toward Streamlining Colon Cancer Care
Oscar Calvillo, Toronto General Hospital
Project: Characterizing Heart And Mind health Post-chemotherapy In Women with early-stage breast cancer (CHAMPION)
Alberto Hernando Calvo, Princess Margaret Cancer Centre
Project: External validation of the VIGEX gene-expression signature as a novel predictive biomarker for immuneoncology (IO) treatments
Hanbo Chen, Sunnybrook Health Sciences Centre
Project: Towards a Better Therapeutic Ratio: The Role of Magnetic Resonance-Linear Accelerator (MR-Linac) in Radiotherapy
Douglas Cheung, Princess Margaret Cancer Centre
Project: Seeing Clearly: A Decision Analysis of MRI, PSMA PET/CT, and Biomarker Testing in Early Prostate Cancer Detection
Sarah Cohen-Gogo, The Hospital for Sick Children
Project: PICTURE: PARP Inhibitors and Chemotherapy for patients harbouring TUmours with homologous REcombination repair deficiency: a phase II pilot study
David Cyr, Mount Sinai Hospital
Project: Clinicopathologic and Molecular Predictors of Outcomes Following Salvage Surgery for Locally Recurrent Rectal Cancer
Alexandra Desnoyers, Princess Margaret Cancer Centre
Project: Fragility Index of Approved Cancer Drugs
Lawson Eng, Princess Margaret Cancer Centre
Project: ONCO-GEMINI: Oncology Continuum General Medicine Inpatient Initiative
Carrillo Estrada, Mount Sinai Hospital
Project: Cardiac Outcomes in Pregnant Cancer Survivors: A Prospective Cohort Study
Sofia Genta, Princess Margaret Cancer Centre
Project: Immune Resistance Interrogation Study (IRIS): evaluating genomic, transcriptomic, epigenetic, immunophenotypic and radiomic profiles associated with primary and acquired resistance to PD1/PD-L1 targeting agents.
Rachel Glicksman, Sunnybrook Health Sciences Centre
Project: Early surrogate measures and predictors of outcome for intermediate risk prostate cancer patients treated with ablative therapies
Robert Grant, SmartCentres Hold’em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Predicting Outcomes in Pancreatic Cancer from Clinical and Genomic Data using Machine Learning
Alexander Gregor, Toronto General Hospital
Project: Enhancing sentinel lymph node mapping in lung cancer surgery using a novel liposome-based dual-modality nanoparticle
Keegan Guidolin, CMCC/Atrium Hold’em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Porphysomes for the intraoperative visualization of colorectal lymph node metastases
Paulo Kayano, Princess Margaret Cancer Centre
Project: Impact of Proton Pump Inhibitors on prostate cancer diagnosis and outcomes
Rachel Kim, CMCC/Atrium Hold’em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Characterization of endometrioid carcinoma of the endometrium: molecular subtype assignment to infirm treatment decisions and improve outcomes
Tristan Knight, RBC Hold'em for Life Oncology Fellow, The Hospital for Sick Children
Project: Re-envisioning the autologous hematopoietic stem cell transplant as immunotherapy
Eyal Lebel, Princess Margaret Cancer Centre
Project: Clinical applications of free DNA in Multiple Myeloma
Jerry Ku, Sunnybrook Health Sciences Centre
Project: Adjuvant 5-aminolevulinic acid-based intraoperative photodynamic therapy of glioblastoma multiforme: A prospective pilot study
Bryan Li, The Hospital for Sick Children
Project: High-throughput drug screening and development of in vivo drug models for pineoblastoma
Shelly Luu, BMO Hold'em for Life Oncology Fellow, Mount Sinai Hospital
Project: Investigation of the Polo-like Kinas 4 Interactome as a Novel Therapeutic Target in Gastric Cancer
Wanda Marini, Katie Hoffman Hold’em for Life Oncology Fellow, Mount Sinai Hospital
Project: The Role of Hedgehog Signaling in Basal-Like Breast Cancer and the Tumor Microenvironment
Kristen McAlpine, Princess Margaret Cancer Centre
Project: Establishing national benchmarks and quality improvement priorities for the surgical care of kidney cancer patients in Canada
Michelle Nadler, Dream Hold’em for Life Oncology Fellow, Women's College Hospital
Project: What are the determinants of breast cancer screening practices for women aged 40-49?
Farshad Nassiri, Toronto Western Hospital
Project: Establishing the utility of a novel plasma-based biomarker to non invasively prognosticate meningiomas
Christopher Noel, Levinsky Waratah Hold’em for Life Oncology Fellowship, Sunnybrook Health Sciences Centre
Project: Symptom Burden as a Predictor of Emergency Room Visits and Unplanned Hospitalizations in Patients with Head and Neck Cancer
Sarah Picardo, Princess Margaret Cancer Centre
Project: Evaluation of the tumour-adjacent microbiota in patients with metastatic genitourinary (GU) cANcers: the URinary and fecal microBiome (URBAN)
Khaled Ramadan, Silverberg Hold’em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Photodynamic Therapy during in vivo lung perfusion for treatment of lung metastases
April Rose, Princess Margaret Cancer Centre
Project: Characterizing mechanisms of response and resistance to binimetinib and encorafenib in advanced cancers with non- V600E BRAF mutations: correlative analyses of the BEAVER trail
Abdulazeez Salawu, Mount Sinai Hospital
Project: Circulating Tumor DNA Detection in Soft Tissue Sarcoma (DNATSAR)
Carlos Stecca, Princess Margaret Cancer Centre
Project: Feasibly Integrating Epigenomic and Genomic Liquid Biopsy Biomarkers
Michael Taccone, The Hospital for Sick Children
Project: Mitochondrial Fission: Targeting the Achilles' Heel of Glioblastoma
Abi Vijenthira, The Gerald Schwartz & Heather Reisman Foundation Hold'em For Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Application of the Generalizable Frailty Index using population-based health administrative data in older patients with diffuse large B-cell lymphoma (DLBCL), with further sensitivity analyses using a smaller cohort with detailed pathologic and cancer-specific data
Mathew Voisin, Toronto Western Hospital
Project: Liquid biopsy of gliomas by absolute quantification of IDH mutation
Pei Jye Voon, Princess Margaret Cancer Centre
Project: Measurement of psychometric properties of the Functional Assessment of Cancer Therapy – Immune Checkpoint Modulators (FACT-ICM) health related quality of life tool in patients treated with durvalumab and oleclumab in various solid tumors
Geoff Watson, Princess Margaret Cancer Centre
Project: Evaluating the Integrative Role of Regulatory T Cells, Myeloid-Derived Suppressor Cells, Inflammatory Cytokines and Neutrophil-Lymphocyte Ratio as Biomarkers of Response and Toxicity in Patients with Advanced Stage Cancer Treated with Pembrolizumab
Irene Xie, CIBC Capital Markets Hold’em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Identifying molecular vulnerabilities in pancreatic cancer
Zsolt Zador, The Hospital for Sick Children
Project: Exploring the spectrum of cell identities and treatment vulnerabilities in K27M pediatric gliomas
Zubair Bayat, Mount Sinai Hospital
Project: Toward Streamlining Colon Cancer Care
Oscar Calvillo, Toronto General Hospital
Project: Characterizing Heart And Mind health Post-chemotherapy In Women with early-stage breast cancer (CHAMPION)
Vaibhav Gupta, Sunnybrook Health Sciences Centre
Project: Development and external validation of a personalized model to predict survival in esophageal cancer patients
Otto Hemminki, SmartCentres Hold’em for Life Oncology Fellow, Mount Sinai Hospital
Project: Transforming care for high-risk muscle-invasive bladder cancer using fast-tracked new MRI techniques and radiomics to decrease time to cystectomy
Paulo Kayano, Princess Margaret Cancer Centre
Project: Impact of Proton Pump Inhibitors on prostate cancer diagnosis and outcomes
Shelly Luu, BMO Hold'em for Life Oncology Fellow, Mount Sinai Hospital
Project: Investigation of the Polo-like Kinas 4 Interactome as a Novel Therapeutic Target in Gastric Cancer
Wanda Marini, Katie Hoffman Hold’em for Life Oncology Fellow, Mount Sinai Hospital
Project: The Role of Hedgehog Signaling in Basal-Like Breast Cancer and the Tumor Microenvironment
Dave Mealiea, Mount Sinai Hospital
Project: Investigation and Design of Oncolytic Vaccinia Virus-Based Therapies in Colorectal Cancer
Ying Meng, Sunnybrook Health Sciences Centre
Project: Liquid biopsy of brain tumours using MR-guided focused ultrasound-induced blood-brain barrier disruption
Michelle Nadler, Dream Hold’em for Life Oncology Fellow, Women's College Hospital
Project: What are the determinants of breast cancer screening practices for women aged 40-49?
Gregory Nason, CentreCourt Hold’em for Life Oncology Fellow, Princess Margaret Cancer Centre
Project: Comparison of OpeN VErsus RoboTic (CONVERT) Partial Nephrectomy Trial- a feasibility randomized control trial
Farshad Nassiri, Toronto Western Hospital
Project: Establishing the utility of a novel plasma-based biomarker to non invasively prognosticate meningiomas
Sarah Picardo, Princess Margaret Cancer Centre
Project: Evaluation of the tumour-adjacent microbiota in patients with metastatic genitourinary (GU) cANcers: the URinary and fecal microBiome (URBAN)
Jenna Spring, Mount Sinai Hospital
Project: Early Advance Care Planning in Hematologic Malignancies and Hematopoietic Stem Cell Transplants: A Pre-Post Pilot Study
Carlos Stecca, Princess Margaret Cancer Centre
Project: Feasibly Integrating Epigenomic and Genomic Liquid Biopsy Biomarkers